Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

This news of Ozempic price cuts comes on the heels, or tablet, of Novo Nordisk developing a weight loss pill that mirrors the ...

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the ...

Microsoft cofounder and billionaire philanthropist Bill Gates has said he would give India "an A" for its focus on solving ...

While the race for the next big weight loss solution heats up, a Danish pharmaceutical company says its oral weight loss drug ...

We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going ...

Amycretin mimics the actions of glucagon-like peptide-1 (GLP-1) and amylin, hormones that play a role in reducing blood sugar ...

Amycretin, an oral weight loss pill developed by the makers of Wegovy, led to a 13.1% weight loss over three months in early ...

Amycretin, an oral weight loss drug, led to up to 13% body weight reduction in three months, showing potential for continued ...

A daily diet pill has shown promising results in early trials, with participants losing an average of 13% of their body ...

Terns Pharmaceuticals (NASDAQ: TERN) is one of them. The fledgling clinical-stage drugmaker recently reported positive ...